Carl Zeiss Meditec AG (ETR:AFX)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as €113.60 ($132.09) and last traded at €111.90 ($130.12), with a volume of 160651 shares changing hands. The stock had previously closed at €103.10 ($119.88).
Several equities research analysts have recently issued reports on AFX shares. HSBC set a €109.00 ($126.74) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Tuesday. DZ Bank reiterated a “neutral” rating on shares of Carl Zeiss Meditec in a report on Tuesday. Kepler Capital Markets set a €80.00 ($93.02) price target on Carl Zeiss Meditec and gave the company a “sell” rating in a report on Friday, December 6th. Berenberg Bank set a €93.00 ($108.14) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Friday, December 6th. Finally, Nord/LB set a €98.00 ($113.95) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Thursday, October 24th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. Carl Zeiss Meditec presently has an average rating of “Hold” and a consensus price target of €100.86 ($117.28).
The company has a fifty day moving average of €103.50 and a two-hundred day moving average of €97.82. The company has a current ratio of 4.11, a quick ratio of 3.09 and a debt-to-equity ratio of 4.55. The stock has a market capitalization of $10.11 billion and a price-to-earnings ratio of 66.00.
About Carl Zeiss Meditec (ETR:AFX)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Recommended Story: Dollar Cost Averaging
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.